News
LFCR
5.17
-4.08%
-0.22
Weekly Report: what happened at LFCR last week (0615-0619)?
Weekly Report · 4d ago
Analysts Conflicted on These Healthcare Names: Anteris Technologies Global Corp. (AVR), Lifecore Biomedical (LFCR) and Biogen (BIIB)
TipRanks · 06/18 12:30
Lifecore Biomedical Is Maintained at Outperform by Barrington Research
Dow Jones · 06/16 12:37
Lifecore Biomedical Price Target Raised to $6.50/Share From $6.00 by Barrington Research
Dow Jones · 06/16 12:37
Barrington Research Maintains Outperform on Lifecore Biomedical, Raises Price Target to $6.5
Benzinga · 06/16 12:27
Lifecore price target raised to $6.50 from $6 at Barrington
TipRanks · 06/16 11:36
Lifecore signs agreement with global pharmaceutical company
TipRanks · 06/15 11:45
Lifecore Biomedical signs tech transfer, commercial manufacturing deal for marketed neurology injectable suspension
PUBT · 06/15 11:05
LIFECORE BIOMEDICAL SIGNS NEW AGREEMENT WITH GLOBAL PHARMACEUTICAL COMPANY
Reuters · 06/15 11:05
Weekly Report: what happened at LFCR last week (0608-0612)?
Weekly Report · 06/15 10:11
Weekly Report: what happened at LFCR last week (0601-0605)?
Weekly Report · 06/08 10:08
Lifecore Shareholders Approve New 2026 Stock Incentive Plan
TipRanks · 06/05 20:39
Lifecore signs manufacturing pact with ophthalmic disease management provider
TipRanks · 06/02 11:30
Lifecore Biomedical Signs Manufacturing Services Agreement To Perform Process Development And Technical Transfer Services In Support Of Anticipated Commercial Manufacturing Upon Regulatory Approval
Benzinga · 06/02 11:06
Lifecore Biomedical signs manufacturing services deal with new ophthalmic customer
PUBT · 06/02 11:06
LIFECORE BIOMEDICAL SIGNS AGREEMENT WITH NEW BIOPHARMACEUTICAL CUSTOMER
Reuters · 06/02 11:05
Weekly Report: what happened at LFCR last week (0525-0529)?
Weekly Report · 06/01 10:11
Weekly Report: what happened at LFCR last week (0518-0522)?
Weekly Report · 05/25 10:14
Lifecore Biomedical attends William Blair Growth Stock Conference
PUBT · 05/21 11:08
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
Barchart · 05/21 06:05
More
Webull provides a variety of real-time LFCR stock news. You can receive the latest news about Lifecore Biomedical Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization that provides services in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes, vials and cartridges. It manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. It manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. It also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.